By Steve Scherer ( October 8, 2026, 17:28 GMT | Insight) -- Patent deals linked US and Chinese technology portfolios, renewed smartphone licenses and expanded automotive coverage, while a memory-patent dispute ended in a $600 million settlement. Pharmaceutical partnerships secured rights to treatments for autoimmune disease, obesity, cervical precancer and organ damage.Qualcomm and Huawei agreed to a broad patent cross-license and Qualcomm’s purchase of certain Huawei US patents, while Qualcomm renewed Apple’s global patent license. Micron agreed to pay Netlist $600 million in license fees under agreements settling their litigation, and Volvo Cars joined Avanci’s automotive Wi-Fi pool. Pharmaceutical deals included Novartis licensing an experimental RNA-based autoimmune treatment and Novo Nordisk acquiring rights to a potential weekly weight-loss pill. Other partnerships targeted cervical precancer and kidney and liver diseases....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.